Asymptomatic coinheritance of heterozygous plasminogen deficiency and the factor V-Leiden mutation

被引:12
|
作者
McColl, MD
Tait, RC
Walker, ID
McCall, F
Conkie, JA
Perry, DJ
机构
[1] ROYAL INFIRM,DEPT HAEMATOL,GLASGOW G31 2ER,LANARK,SCOTLAND
[2] SO GEN HOSP NHS TRUST,GLASGOW,LANARK,SCOTLAND
[3] ROYAL FREE HOSP,SCH MED,LONDON,ENGLAND
关键词
plasminogen; factor V-Leiden mutation;
D O I
10.1097/00001721-199704000-00007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Deficiency of plasminogen has been postulated by some authors as a possible thrombophilic abnormality, though this remains controversial. We have previously identified a cohort of individuals with plasminogen deficiency from a study to determine plasminogen levels within the general population. All were asymptomatic for thrombosis at initial identification. We followed this cohort over a 5-year period, with no venous thrombotic events recorded, although one patient did suffer a myocardial infarction. One family was identified with asymptomatic coinheritance of both plasminogen deficiency and the factor V(Leiden)mutation. There was no apparent venous thrombotic risk conferred upon any of our cohort of individuals by inheritance of plasminogen deficiency, and, in addition, the combination of the factorV(Leiden) mutation with plasminogen deficiency which was observed in three individuals did not result in thrombotic events. However, the cohort is small and we cannot entirely exclude plasminogen deficiency as a possible mild thrombophilic defect.
引用
收藏
页码:195 / 199
页数:5
相关论文
共 50 条
  • [41] An improved test to identify aPC-resistant factor V-Leiden
    Preda, L
    Erba, N
    Figini, S
    Carniti, GC
    Rossi, E
    THROMBOSIS RESEARCH, 1997, 86 (06) : 461 - 468
  • [42] Thrombosis in patients with heterozygous and homozygous factor XII deficiency is not explained by the associated presence of factor V Leiden
    Castaman, G
    Ruggeri, M
    Tosetto, A
    Missiaglia, E
    Rodeghiero, F
    THROMBOSIS AND HAEMOSTASIS, 1996, 76 (02) : 275 - 275
  • [43] Pseudo-homozygous activated protein C resistance due to coinheritance of heterozygous factor V Leiden mutation and type I factor V deficiency. Variable expression when analyzed by different activated protein C resistance functional assays
    Delahousse, B
    Iochmann, S
    Pouplard, C
    Fimbel, B
    Charbonnier, B
    Gruel, Y
    BLOOD COAGULATION & FIBRINOLYSIS, 1997, 8 (08) : 503 - 509
  • [44] Expression of the normal factor V allele modulates the APC resistance phenotype in heterozygous carriers of the factor V Leiden mutation
    Brugge, JM
    Simoni, PS
    Bernardi, F
    Tormene, D
    Lunghi, B
    Tans, G
    Pagnan, A
    Rosing, J
    Castoldi, E
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (12) : 2695 - 2702
  • [45] Factor v Leiden mutation and preeclampsia
    Rigó, J
    Nagy, B
    Fintor, L
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2002, 186 (04) : 853 - 853
  • [46] Homozygous factor V Leiden and double heterozygosity for factor V Leiden and prothrombin mutation
    Ymir Saemundsson
    Signý Vala Sveinsdottir
    Henrik Svantesson
    Peter J. Svensson
    Journal of Thrombosis and Thrombolysis, 2013, 36 : 324 - 331
  • [47] The distribution of Factor V Leiden mutation
    Eroglu, Aydan
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2013, 36 (03) : 341 - 342
  • [48] Tamoxifen and the Factor V Leiden Mutation
    Cuzick, Jack
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (13) : 918 - U1
  • [49] Factor V Leiden mutation in Turkish patients with homozygous cystathionine β-synthase deficiency
    Kalkanoglu, HS
    Coskun, T
    Aydogdu, SD
    Tokatli, A
    Gürgey, A
    JOURNAL OF INHERITED METABOLIC DISEASE, 2001, 24 (03) : 367 - 369
  • [50] Factor V Leiden mutation and pregnancy
    Langan, RC
    JOURNAL OF THE AMERICAN BOARD OF FAMILY PRACTICE, 2004, 17 (04): : 306 - 308